Red Abbey Labs (RAL) is a patient-centered, hypothesis and technology driven, capital efficient neuRALinnovation group with a mission to solve degenerative conditions. We are scientists, engineers, clinicians, entrepreneurs, and investors who acknowledge the prevailing science, technology, and business barriers, but are driven by a collective desire to see effective solutions reach patients quickly and cost-effectively.
RAL achieves this by pursuing human-derived evidence, enabling technologies, promising hypotheses, and safe therapeutic interventions. In collaboration with our partners, we create translational value through execution and early financing of virtual and semi-virtual research. RAL has initiated work to optimize therapeutic agents for the treatment of neurological conditions.
Inspiring hypothesis-driven breakthroughs
Exploiting technology-enabled platforms
Managing capital-efficient innovation
Building patient-centered solutions
Company Details
Red Abbey Labs Questions
Red Abbey Labs's LinkedIn profile is https://www.linkedin.com/company/redabbeylabs
Red Abbey Labs has
10 employees.
View email and phone details for 10
employees at Red Abbey Labs.
Red Abbey Labs's industry is
Biotechnology Research
Red Abbey Labs's top competitors are
Acidophil Llc,
Molecule Ag,
The Rugby Portobello Trust,
Garden Studios,
Onmiddan,
Pointe Advisory,
Mercury Capital Management,
Medtheia,
Vivoverse,
Cicada.
Red Abbey Labs's categories are Biotechnology Research
